Herve Tiriac

Herve Tiriac

University of California, San Diego

H-index: 21

North America-United States

About Herve Tiriac

Herve Tiriac, With an exceptional h-index of 21 and a recent h-index of 20 (since 2020), a distinguished researcher at University of California, San Diego, specializes in the field of Cancer research, Pancreatic Cancer, Organoid.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract A056: Targeting the mevalonate biosynthesis pathway in gemcitabine resistant pancreatic cancer

Abstract B096: Acquired resistance to KRAS inhibition modulates the pancreatic cancer tumor microenvironment

Abstract A039: Silencing MICAL2 expression in pancreatic cancer cells reduces IL-1A expression and inhibits tumor growth through a CD8+ T cell dependent mechanism

The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient–derived organoids

Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma

An ex-vivo organotypic culture platform of mucinous carcinomatosis peritonei identifies CDK4-6 inhibition as a novel treatment

Resistance to RAS inhibition promotes remodeling of the immunosuppressive microenvironment of pancreatic cancer

The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer

Herve Tiriac Information

University

Position

Department of Surgery

Citations(all)

8758

Citations(since 2020)

6991

Cited By

4367

hIndex(all)

21

hIndex(since 2020)

20

i10Index(all)

29

i10Index(since 2020)

29

Email

University Profile Page

Google Scholar

Herve Tiriac Skills & Research Interests

Cancer research

Pancreatic Cancer

Organoid

Top articles of Herve Tiriac

Abstract A056: Targeting the mevalonate biosynthesis pathway in gemcitabine resistant pancreatic cancer

Cancer Research

2024/1/16

Abstract B096: Acquired resistance to KRAS inhibition modulates the pancreatic cancer tumor microenvironment

Cancer Research

2024/1/16

Abstract A039: Silencing MICAL2 expression in pancreatic cancer cells reduces IL-1A expression and inhibits tumor growth through a CD8+ T cell dependent mechanism

Cancer Research

2024/1/16

Jay Patel
Jay Patel

H-Index: 5

Herve Tiriac
Herve Tiriac

H-Index: 16

The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient–derived organoids

JCI insight

2024/1/1

Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma

Nature cancer

2024/1

An ex-vivo organotypic culture platform of mucinous carcinomatosis peritonei identifies CDK4-6 inhibition as a novel treatment

Cancer Research

2024/3/22

Resistance to RAS inhibition promotes remodeling of the immunosuppressive microenvironment of pancreatic cancer

Cancer Research

2024/3/22

Herve Tiriac
Herve Tiriac

H-Index: 16

The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer

Scientific reports

2024/3/16

Herve Tiriac
Herve Tiriac

H-Index: 16

Brian A Van Tine
Brian A Van Tine

H-Index: 52

Engrailed‐1 Promotes Pancreatic Cancer Metastasis

Advanced Science

2024/2

Abstract C114: Engrailed-1 promotes pancreatic cancer metastasis

Cancer Research

2024/1/16

Inhibiting stromal Class I HDACs curbs pancreatic cancer progression

Nature Communications

2023/12/6

Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma

Cancer research

2023/9/15

A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer

Nature communications

2023/9/6

Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia

Oncogene

2023/8/18

Building a 3D co-culture model for metastatic pancreatic ductal cancer using Curiochips microphysiological system

Cancer Research

2023/4/4

The impact of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids

bioRxiv

2023/1/27

Synergism between SUMO inhibition and irreversible electroporation for pancreatic cancer

HPB

2023/1/1

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an …

Journal for Immunotherapy of Cancer

2023

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

JoVE (Journal of Visualized Experiments)

2022/12/9

Abstract C044: MICAL2 expression in pancreatic cancer cells modulates the tumor microenvironment through the TGF beta pathway

Cancer Research

2022/11/15

See List of Professors in Herve Tiriac University(University of California, San Diego)